Parallel Versus Perpendicular Technique for Lumbar Medial Branch Radiofrequency Neurotomy
Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · Apr 9, 2019
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial is studying two different techniques for a treatment called lumbar medial branch radiofrequency neurotomy (LMBRFN), which is used to help relieve low back pain that comes from specific joints in the lower spine. Researchers want to find out if using different types of needles and approaches (called “parallel” and “perpendicular”) makes a difference in how well patients respond to the treatment. The goal is to see which technique provides better pain relief and for how long.
To participate in the trial, you need to be over 40 years old and have been experiencing low back pain for at least two months that hasn’t improved with physical therapy or pain medication. You also need to show significant improvement (at least 80%) after two specific tests called lumbar medial branch blocks. If you qualify and decide to join, you’ll receive one of the two treatment techniques and will attend follow-up appointments to monitor your progress. It's important to know that this trial has strict criteria for participation to ensure the best results, and it aims to help determine the most effective method for treating low back pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged \> 40, capable of understanding and providing consent in English, capable of complying with the outcome instruments used, capable of attending all planned follow up visits
- • unilateral or bilateral low back pain of at least 4/10 on Numeric Pain Rating Scale (NPRS) present for at least 2 months that has failed to adequately respond to at least 6 weeks of physical therapy and oral pain medication
- • at least 80% improvement on two consecutive lumbar medial branch blocks of no more than a total of 4 lumbar facet joints
- • beyond the above stated criteria, the decision to initiate the process of a first medial branch block is based on clinical decision making of the treating physician
- • Patient consents to treatment in a shared decision-making process with the treating physician.
- Exclusion Criteria:
- • Those whose primary complain is lumbar radiculopathy
- • Those receiving remuneration for their pain treatment (e.g., disability, worker's compensation).
- • Those involved in active litigation relevant to their pain.
- • Those unable to read English and complete the assessment instruments.
- • Those unable to attend follow up appointments
- • The patient is incarcerated.
- • History of prior lumbar fusion
- • Progressive motor deficit, and/or clinical signs of cauda equina or polyradiculopathy
- • History of lumbar steroid injection (epidural steroid injection, sacroiliac joint steroid injection, lumbar facet steroid injection) within the prior 3 months.
- • Possible pregnancy or other reason that precludes the use of fluoroscopy.
- • Allergy to contrast media or local anesthetics.
- • BMI\>40.
- • Active Systemic inflammatory arthritis (e.g., rheumatoid arthritis, ankylosing spondylitis, lupus).
- • Active infection or treatment of infection with antibiotics within the past 7 days.
- • Medical conditions causing significant functional disability (e.g., stroke, COPD)
- • Chronic widespread pain or somatoform disorder (e.g. fibromyalgia).
- • Addictive behavior, severe clinical depression, or psychotic features.
About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is a leading academic medical center located in Nashville, Tennessee, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, VUMC integrates cutting-edge scientific inquiry with patient-centered care, supporting a diverse array of studies aimed at enhancing medical knowledge and improving treatment outcomes. With a robust infrastructure and a multidisciplinary team of experts, VUMC fosters collaboration across various fields, ensuring the highest standards of safety and ethical considerations in its research endeavors. Through its dedication to medical discovery and education, VUMC plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Patients applied
Trial Officials
Byron Schneider, MD
Principal Investigator
Vanderbilt University Medical Center
Blake Fechtel, MD MSc
Study Director
Vanderbilt University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials